← 홈

전체 프로그램

ADC 1068 · Antibody 5456 · CGT 2744 · 다음 갱신 D-12 · 마지막 7월 13일

인기최근 업데이트큐레이션임상 많은갱신 필요ORR최신Phase 3FDA승인프로그램 4,162개
ADCBiologicstaleBioNTech SEPhase 2

Paroxetine (Paroxetine)

Advanced Solid Tumor · Advanced Solid Tumor

#AdvancedSolidTumor#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+1
임상시험 31상태 RECRUITING
ADCBiologicstaleMerckPhase 2

pembrolizumab (Keytruda, Pembrolizumab + Enfortumab Vedotin)

Bellini Carcinoma; Collecting Duct Carcinoma · Bellini Carcinoma

#BelliniCarcinoma#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+2
효능 ORR 6%임상시험 31상태 RECRUITING
AntibodystaleMerckPhase 2

pembrolizumab (Keytruda, Pembrolizumab - 4 cycle)

Breast Neoplasms; Breast Cancer · HER2

#HER2#Antibody#Phase2#항체#면역항체+4
효능 ORR 84%임상시험 31상태 RECRUITING
AntibodystaleMerckPhase 2

pembrolizumab (Keytruda, Pembrolizumab - 8 cycle)

Breast Neoplasms; Breast Cancer · HER2

#HER2#Antibody#Phase2#항체#면역항체+4
효능 ORR 25%임상시험 31상태 RECRUITING
ADCBiologicstaleCastilla-La Mancha Health Servi…Phase 2

Perioperative treatment (Perioperative treatment)

Hepatoid Adenocarcinoma of Stomach · Hepatoid Adenocarcinoma of Stomach

#HepatoidAdenocarcinomaofStomach#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+1
임상시험 31상태 RECRUITING
AntibodystaleRochePhase 2

trastuzumab (Herceptin, Pertuzumab + trastuzumab)

Elderly Metastatic Breast Cancer Population · Elderly Metastatic Breast Cancer Populat

#ElderlyMetastaticBreastCancerPop#Antibody#Phase2#항체#면역항체+2
효능 ORR 69.3%임상시험 31상태 ACTIVE
AntibodystaleRochePhase 2

trastuzumab (Herceptin, Pertuzumab and Trastuzumab)

Breast Neoplasms; Breast Cancer · HER2

#HER2#Antibody#Phase2#항체#면역항체+4
효능 ORR 69.3%임상시험 31상태 RECRUITING
ADCBiologicstaleInstitut Claudius RegaudApproved

Pharmacokinetics blood samples (Pharmacokinetics blood samples)

Locally Advanced or Metastatic Breast Cancers · Locally Advanced or Metastatic Breast Ca

#LocallyAdvancedorMetastaticBreas#ADC#Approved#항체약물접합체#antibody-drug-conjugate+1
효능 ORR 91.2%임상시험 31상태 RECRUITING
ADCBiologicstaleSanofi Pasteur, a Sanofi CompanyPreclinical

Pneumococcal Conjugate Vaccine, Heptavalent (Pneumococcal Conjugate Vaccine, Heptavalent)

HIV Infections; Hepatitis B · HIV Infections

#HIVInfections#ADC#Preclinical#항체약물접합체#antibody-drug-conjugate+2
임상시험 31상태 ACTIVE
ADCBiologicstaleCzech Lymphoma Study GroupPhase 2

Prednisone tablet (Prednisone tablet)

Lymphoma, T-Cell, Peripheral · Lymphoma, T-Cell, Peripheral

#LymphomaT-CellPeripheral#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+4
효능 ORR 16.8%임상시험 31상태 ACTIVE
ADCBiologicstalechenxuPhase 2

Probiotic (Probiotic)

Muscle Invasive Bladder Cancer (MIBC) · Muscle Invasive Bladder Cancer (MIBC)

#MuscleInvasiveBladderCancerMIBC#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+1
임상시험 31상태 RECRUITING
ADCBiologicstalePharmacyclics LLC.Phase 3

Procarbazine Hydrochloride (Procarbazine Hydrochloride)

Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8 · Lugano Classification Limited Stage Hodg

#LuganoClassificationLimitedStage#ADC#Phase3#항체약물접합체#antibody-drug-conjugate+1
효능 ORR 1%임상시험 31상태 RECRUITING
ADCBiologicstaleAstraZenecaPhase 3

Rilvegostomig (Rilvegostomig)

Hepatocellular Carcinoma · Endometrial Cancer

#EndometrialCancer#ADC#Phase3#항체약물접합체#antibody-drug-conjugate+2
임상시험 31상태 RECRUITING
ADCBiologicstaleBellicum PharmaceuticalsPhase 2

Rimiducid (Rimiducid)

Acute Lymphoblastic Leukemia; Leukemia, Acute Myeloid (AML), Child · Breast Cancer

#BreastCancer#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+4
임상시험 31상태 RECRUITING
AntibodystaleRochePreclinical

Mabthera®, Roche Pty Ltd, Basel, Switzerland (Rituximab, Rituximab (Mabthera®, Roche Pty Ltd, Basel, Switzerland))

Non Hodgkin Lymphoma · Non Hodgkin Lymphoma

#NonHodgkinLymphoma#Antibody#Preclinical#항체#면역항체+2
효능 ORR 4%임상시험 31상태 ACTIVE
AntibodyBiologicstaleSeagen Inc.Phase 2

anti-CD30 mAb (SGN-30, SGN-30 (anti-CD30 mAb))

Anaplastic Large-Cell Lymphoma · CD30

#CD30#Antibody#Phase2#항체#면역항체+3
효능 ORR 89.5%임상시험 31상태 ACTIVE
ADCBiologicstaleSeagen Inc.Phase 2

SGN-35 (SGN-35)

Disease, Hodgkin; Lymphoma, Large-Cell, Anaplastic · Disease, Hodgkin

#DiseaseHodgkin#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+4
효능 ORR 89.5%임상시험 31상태 ACTIVE
ADCBiologicstaleMerck Sharp & Dohme LLCPhase 1

sacituzumab govitecan (Trodelvy, Sacituzumab)

Muscle Invasive Bladder Urothelial Carcinoma · Muscle Invasive Bladder Urothelial Carci

#MuscleInvasiveBladderUrothelialC#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+1
효능 ORR 33.3%임상시험 31상태 ACTIVE
CGTBiologicstaleWuhan Sian Medical Technology C…Phase 2

Second generation CAR-T cells (Second generation CAR-T cells)

Acute Lymphoblastic Leukemia; B Cell Lymphoma · Acute Lymphoblastic Leukemia

#AcuteLymphoblasticLeukemia#CGT#Phase2#세포유전치료#CAR-T+3
임상시험 31상태 ACTIVE
ADCBiologicstaleRemeGen Co., Ltd.Phase 2

Sequential CTX (Sequential CTX)

Breast Cancer · Breast Cancer

#BreastCancer#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+1
효능 ORR 81.1%임상시험 31상태 RECRUITING

30 / 209 페이지

← 이전다음 →